Funded Startups in HaMerkaz
The largest disclosed round in the HaMerkaz list is NextVision Stabilized Systems’ $196M on 2026-06-18, which dwarfs the rest of the disclosed amounts—no o…
The largest disclosed round in the HaMerkaz list is NextVision Stabilized Systems’ $196M on 2026-06-18, which dwarfs the rest of the disclosed amounts—no other disclosed entry exceeds $180M (ZOOZ Power, $180M on 2025-07-29), and the next-largest figures cluster far below that peak (for example Enlivex Therapeutics at $212M on 2025-11-24 is above $196M, making NextVision the largest shown only if restricting to the single most recent peak; the actual largest disclosed amount in the rows is actually Nostromo’s $306M on 2024-12-09, which stands out against all other disclosed rounds). Multiple concentrations appear in both time and geography: rounds run from 2024-07-31 (Viridix, undisclosed) through 2026-06-30 (Collplant, $3M), with several large checks landing in late 2025 (e.g., Enlivex Therapeutics $212M on 2025-11-24; Chargeflow $25M on 2025-11-19; Fetcherr $42M on 2025-09-28). On location, the entries repeatedly cite Rehovot, Ness Ziona, and Petah Tiqva (e.g., Collplant in Rehovot on 2026-06-30; Quantum Art in Ness Ziona on 2026-04-27; BOB FoodTech in Rehovot on 2024-10-21; PolyPid in Petah Tiqva on 2024-08-01). Stage disclosures are also mixed: 25 of 50 rows are “Series Unknown,” and 3 are explicitly “undisclosed,” with disclosed Series A/B/C/D appearing alongside those gaps.
Most recent rounds
50 of 167117 more funded startups
This page shows the 50 most recent rounds (back to Jul 2024). The full 167-company history for this listing is available on a paid plan.
Unlock all 167 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the biggest disclosed round in the HaMerkaz set, and how separated is it from the next tier?
Nostromo’s $306M round (2024-12-09) is the clear disclosed outlier. The next-largest disclosed entries include ZOOZ Power at $180M (2025-07-29) and Enlivex Therapeutics at $212M (2025-11-24), with all other disclosed rounds below the high-$100M range.
Are there temporal clusters in the most recent activity window shown?
There are multiple multi-month bursts rather than evenly spaced rounds: for example, June 2026 includes Collplant ($3M on 2026-06-30), Raziel Therapeutics (undisclosed on 2026-06-29), and NextVision Stabilized Systems ($196M on 2026-06-18). A second concentration shows up in late 2025, including Enlivex Therapeutics ($212M on 2025-11-24) and Fetcherr ($42M on 2025-09-28).
Which cities recur most in this listing, suggesting a local concentration?
Rehovot, Ness Ziona, and Petah Tiqva appear repeatedly across different companies and dates. Examples include Collplant in Rehovot (2026-06-30) and BOB FoodTech in Rehovot (2024-10-21), Quantum Art in Ness Ziona (2026-04-27) and PolyPid in Petah Tiqva (2024-08-01).
How dominant is stage ambiguity here, and do disclosed stages still form recognizable groups?
25 of 50 rows are labeled “Series Unknown,” while 3 are “undisclosed” on amount. Even with that gap, disclosed rounds cluster around named early-to-mid stages, such as multiple Series A checks (Quantum Art $40M on 2026-04-27; MetaSight Diagnostics $8M on 2024-11-13; Enzymit $10M on 2024-09-25).
Do any sectors look over-represented relative to others in the dataset?
Biotechnology shows up heavily across the rows (e.g., Collplant $3M on 2026-06-30; Scinai Immunotherapeutics $3M on 2026-04-24; CanFite BioPharma $4M on 2026-03-04; Evogene $6M on 2024-08-23; PolyPid $8M on 2024-08-01). Other sectors appear in fewer entries by comparison, like Consumer Electronics with multiple consecutive mentions in 2026 and 2024 (NextVision Stabilized Systems $196M on 2026-06-18; D-Fend Solutions $31M on 2024-12-04).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.